BlackBio Launches a Fast and Reliable Diagnostic Solution for Fungi and Yeast Identification
Product News Dec 01, 2010
• Universal: Allows the identification of any fungi and yeasts species without prior knowledge of the etiology of infection. Valid in cases of coinfections.
• Fast: Diagnosis can be completed in less than 4 hours.
• Simple: Minimal handling steps and performance possible even with small sample amounts.
During last years there has been an exponential increase in the incidence of serious fungal infections with high morbidity and mortality. These are often associated with surgery, organ transplants, tumours and intensive care patients. The nature of the infection depends on the underlying disease, and the epidemiology of the infections is changing in parallel with advances in clinical practice, transforming the risk population. Currently, diagnostic tests are trying to obtain faster and more reliable results allowing identification of patients who are potential candidates for receiving early antifungal treatment in order to improve the prognosis and treatment.
All this justifies the need for a fast, easy and cost-competitive Kit for the diagnostic of fungi and yeast (media culture are still very slow and serological tests do not have the desired sensitivity and specificity).
For this reason, Blackbio within its line of Microbiology has launched BlackLight Fungal ID Kit which allows the detection and identification of fungi and yeast in a biological sample with high sensibility and specificity. Handling is minimal with these kits minimizing possible contamination, and it is faster than any traditional method for fungal identification, as diagnostic can be completed in less than 4 hours, instead of the present two to five.
BlackLight Fungal ID kit has been widely tested in hospitals with clinical samples that have allowed the identification not only of the most common fungi and yeasts such as Candida spp. or Aspergillus spp., but also others less frequent or with lower incidence.
Blackbio goes a step forward in his microbiology line and expands its portfolio with this product for the molecular diagnostic of bacterial and fungi infections in a short time, optimizing the appropriate antifungal treatment to improve prognosis and treatment of infection, thus avoiding resistances and improving survival.